Vivek Das/LinkedIn
Jul 31, 2026, 07:54
Vivek Das: From Inflammation to Integrated Precision Cardiovascular Care
Vivek Das, Lead Data Scientist at Novo Nordisk, shared a post on LinkedIn:
“A timely review from the European Society of Cardiology highlights an important direction for precision cardiovascular medicine.
While inflammation remains a key driver of coronary artery disease, meaningful progress will increasingly depend on integrating biomarkers, imaging, multi-omics, and clinical evidence to better understand residual risk and support more individualized care.
Equally important, translating these advances into practice will require robust evidence, careful validation, and thoughtful implementation.
An insightful read for anyone interested in the future of biomarkers and precision medicine.”
Stay updated with Hemostasis Today.
-
Jul 31, 2026, 09:36Konstanze Aurich: Emerging Blood-Derived Products in Transfusion Medicine
-
Jul 31, 2026, 09:21Caitlin Raymond: Does Drinking More Calcium and Magnesium Every Day Raise the Calcium in My Blood?
-
Jul 31, 2026, 09:04Quentin Hill: Collaborative Progress in Immune Thrombocytopenia Drug Development
-
Jul 31, 2026, 07:31Krishna Athmakuri: Evaluating Left Atrial Appendage Occlusion Against Oral Anticoagulation
-
Jul 31, 2026, 04:35Lukas Bastian Otto: Bow Hunter’s Syndrome as a Hidden Cause of Cerebellar Infarction
-
Jul 31, 2026, 04:05Shadi Tabibian: Understanding Thrombotic Risk in Rare Bleeding Disorders
-
Jul 31, 2026, 03:43American Society of Hematology Opens Doors to Hematology Education Worldwide
-
Jul 31, 2026, 03:23Roberta Gualtierotti: Major Genomic Study Identifies Novel Fibromyalgia Risk Genes
-
Jul 30, 2026, 18:36Amina Ammar: Evaluating Rivaroxaban Dosing Alignment Across Cockcroft–Gault and eGFR Equations